Taligen Therapeutics Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$479M
Taligen Therapeutics General Information
Description
Provider of development stage biotechnology services for the treatment of inflammatory diseases. The company is developing therapies that regulate the complement system to treat inflammatory and immune diseases.
Contact Information
Website
www.taligentherapeutics.comCorporate Office
- Cambridge, MA
- United States
Corporate Office
- Cambridge, MA
- United States
Taligen Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 28-Jan-2011 | $479M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 23-Aug-2010 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 01-Aug-2006 | $3.7M | $3.7M | Completed | Product Development |
Taligen Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Taligen Therapeutics Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alta Partners | Venture Capital | Minority | ||
| High Country Venture | Venture Capital | Minority | ||
| Sanderling Ventures | Venture Capital | Minority | ||
| University License Equity Holding | Corporation | Minority |
Taligen Therapeutics FAQs
-
When was Taligen Therapeutics founded?
Taligen Therapeutics was founded in 2004.
-
Where is Taligen Therapeutics headquartered?
Taligen Therapeutics is headquartered in Cambridge, MA.
-
What industry is Taligen Therapeutics in?
Taligen Therapeutics’s primary industry is Drug Discovery.
-
Is Taligen Therapeutics a private or public company?
Taligen Therapeutics is a Private company.
-
What is the current valuation of Taligen Therapeutics?
The current valuation of Taligen Therapeutics is .
-
What is Taligen Therapeutics’s current revenue?
The current revenue for Taligen Therapeutics is .
-
How much funding has Taligen Therapeutics raised over time?
Taligen Therapeutics has raised $78.7M.
-
Who are Taligen Therapeutics’s investors?
Alta Partners, High Country Venture, Sanderling Ventures, and University License Equity Holding have invested in Taligen Therapeutics.
-
When was Taligen Therapeutics acquired?
Taligen Therapeutics was acquired on 28-Jan-2011.
-
Who acquired Taligen Therapeutics?
Taligen Therapeutics was acquired by Alexion.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
